Company Filing History:
2 out of 2 
1 out of 225 
1 out of 5,470 
Years Active: 2014-2024
Title: Shuhui Wang: Innovator in Pharmaceutical Chemistry
Introduction
Shuhui Wang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for cancer treatment. With a total of 5 patents, his work has garnered attention for its potential therapeutic applications.
Latest Patents
One of Wang's latest patents is focused on pyridinylaminopyrimidine derivatives. This invention relates to compounds that can selectively inhibit the activity of mutant-type epidermal growth factor receptor (EGFR). These derivatives have shown promising results in inhibiting cancer cell proliferation, making them potential therapeutic agents for treating tumors and related diseases.
Career Highlights
Wang has worked with notable organizations such as Shanghai Allist Pharmaceuticals Co., Ltd. and Tongji University. His experience in these institutions has allowed him to advance his research and contribute to the development of effective pharmaceutical solutions.
Collaborations
Wang has collaborated with esteemed colleagues, including Huibing Luo and Huayong Zhou. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the field.
Conclusion
Shuhui Wang's innovative contributions to pharmaceutical chemistry highlight his dedication to advancing cancer treatment. His patents and collaborations reflect a commitment to improving therapeutic options for patients.